
Radiology AI software provider Gleamer expands into MRI with two small acquisitions
As the medical imaging industry shifts towards preventive imaging, radiologists are facing a daunting task. Without AI assistance, they typically identify cancer in only three out of five cases. However, innovative companies like Gleamer are revolutionizing the space by providing AI-powered tools that can make a significant impact.
In an effort to address this issue, Gleamer, a French startup, has announced its expansion into MRI technology through two small acquisitions. This strategic move is crucial as it will allow the company to leverage its existing AI expertise in radiology to improve patient outcomes and reduce healthcare costs.
According to Romain Allouche, CEO of Gleamer, AI could become an “orchestrating and triaging” tool that automates a significant portion of routine imaging examinations. This would enable human radiologists to focus on more complex cases where their skills are truly needed.
The industry is already facing a shortage of radiologists, with some cities struggling to meet the demand for reactive imaging. If the industry shifts towards preventive imaging, AI tools like Gleamer’s will become indispensable.
Gleamer’s technology has the potential to change the face of medical imaging by allowing doctors to detect diseases earlier and more accurately. With its new MRI capabilities, the company is poised to make a significant impact on the healthcare landscape.
The acquisitions are expected to close soon, and we’ll be keeping a close eye on Gleamer as it continues to disrupt the industry.